Radiomics in PET: principles and applications

Radiomics is an evolving field in which the extraction of large amounts of features from diagnostic medical images may be used to predict underlying molecular and genetic characteristics, thereby improving treatment response prediction and prognostication and potentially allowing personalisation of cancer treatment. There is increasing interest in extracting additional data from PET images, particularly novel features that describe the heterogeneity of voxel intensities, but a number of potential limitations need to be recognised and overcome. Nevertheless, some early data suggest that extraction of additional quantitative data may offer further predictive and prognostic information in individual patients.

[1]  Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome , 2011, Radiation oncology.

[2]  Christian Roux,et al.  A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET , 2009, IEEE Transactions on Medical Imaging.

[3]  A. Rutman,et al.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.

[4]  V. Goh,et al.  Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. , 2013, Radiology.

[5]  Vicky Goh,et al.  The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Jonathan A Disselhorst,et al.  Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET. , 2012, International journal of radiation oncology, biology, physics.

[7]  Shan Tan,et al.  Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[8]  Joon Young Choi,et al.  Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[10]  V. Goh,et al.  Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy. , 2013, Radiology.

[11]  Elena Bellan,et al.  Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Robert King,et al.  Textural features corresponding to textural properties , 1989, IEEE Trans. Syst. Man Cybern..

[13]  R. Jeraj,et al.  Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters , 2010, Acta oncologica.

[14]  I. Poon,et al.  Automated radiation targeting in head-and-neck cancer using region-based texture analysis of PET and CT images. , 2009, International journal of radiation oncology, biology, physics.

[15]  J. Bradley,et al.  Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  V. Goh,et al.  Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.

[17]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[18]  Mary M. Galloway,et al.  Texture analysis using gray level run lengths , 1974 .

[19]  Huan Yu,et al.  Coregistered FDG PET/CT-Based Textural Characterization of Head and Neck Cancer for Radiation Treatment Planning , 2009, IEEE Transactions on Medical Imaging.

[20]  Jesús Angulo,et al.  Advanced Statistical Matrices for Texture Characterization: Application to Cell Classification , 2014, IEEE Transactions on Biomedical Engineering.

[21]  F. Brooks,et al.  The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of Tracer Uptake , 2014, The Journal of Nuclear Medicine.

[22]  W. Oyen,et al.  FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Finbarr O'Sullivan,et al.  A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data. , 2003, Biostatistics.

[24]  Issam El-Naqa,et al.  Exploring feature-based approaches in PET images for predicting cancer treatment outcomes , 2009, Pattern Recognit..

[25]  Olivier Gevaert,et al.  Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. , 2012, Radiology.

[26]  Olivier Gevaert,et al.  Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. , 2012, Cancer research.

[27]  Floris H. P. van Velden,et al.  Test-Retest Variability of Various Quantitative Measures to Characterize Tracer Uptake and/or Tracer Uptake Heterogeneity in Metastasized Liver for Patients with Colorectal Carcinoma , 2014, Molecular Imaging and Biology.

[28]  Florent Tixier,et al.  Prognostic value of 18F-FDG PET image-based parameters in oesophageal cancer and impact of tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  Vicky Goh,et al.  Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? , 2013, The Journal of Nuclear Medicine.

[30]  M. Hatt,et al.  Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET , 2012, The Journal of Nuclear Medicine.

[31]  Eun-Seok Choi,et al.  Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[33]  Jochen Herrmann,et al.  Evaluation of intratumoural heterogeneity on 18F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1 , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  Howard Y. Chang,et al.  Decoding global gene expression programs in liver cancer by noninvasive imaging , 2007, Nature Biotechnology.

[35]  N. Thacker,et al.  Quantifying heterogeneity in human tumours using MRI and PET. , 2012, European journal of cancer.

[36]  J L Grashuis,et al.  Texture analysis in radiographs: the influence of modulation transfer function and noise on the discriminative ability of texture features. , 1998, Medical physics.

[37]  F. Brooks,et al.  FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement , 2013, Radiation oncology.

[38]  Johan Wennerberg,et al.  2-Deoxy-2-[18F] fluoro-D-glucose uptake and correlation to intratumoral heterogeneity. , 2007, Anticancer research.

[39]  Kyung-Ja Cho,et al.  Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by 18F-FDG PET/CT in squamous cell carcinoma of the oral cavity , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  Irène Buvat,et al.  Tumor Texture Analysis in 18F-FDG PET: Relationships Between Texture Parameters, Histogram Indices, Standardized Uptake Values, Metabolic Volumes, and Total Lesion Glycolysis , 2014, The Journal of Nuclear Medicine.

[41]  Masayuki Sasaki,et al.  FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules. , 2014, European journal of radiology.

[42]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[43]  R. Gillies,et al.  Quantitative imaging in cancer evolution and ecology. , 2013, Radiology.

[44]  V. Goh,et al.  Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.

[45]  Vicky Goh,et al.  Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  M. Hatt,et al.  Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.

[47]  P. Lambin,et al.  Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability , 2013, Acta oncologica.

[48]  F. O’Sullivan,et al.  Spatial Heterogeneity in Sarcoma 18F-FDG Uptake as a Predictor of Patient Outcome , 2008, Journal of Nuclear Medicine.

[49]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[50]  Philippe Lambin,et al.  Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: a feasibility study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[51]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[52]  F E Turkheimer,et al.  Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography , 2013, Physics in medicine and biology.

[53]  Dimitris Visvikis,et al.  Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non–Small Cell Lung Cancer Tumor Delineation , 2011, The Journal of Nuclear Medicine.

[54]  F O'Sullivan,et al.  Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET. , 2005, Biostatistics.

[55]  M. Hatt,et al.  Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma , 2013, European Journal of Nuclear Medicine and Molecular Imaging.